Literature DB >> 18556708

Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.

Eva Tzelepi, Maria Daniilidou, Vivi Miriagou, Eirini Siatravani, Efthimia Pavlidou, Alexandros Flemetakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18556708     DOI： 10.1093/jac/dkn236

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology.

Authors:  Magnus Unemo; Jo-Anne R Dillon
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing.

Authors:  Angeliki Mavroidi; Eva Tzelepi; Eirini Siatravani; Daniel Godoy; Vivi Miriagou; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

Review 3.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

4.  Cephalosporin Resistance in Neisseria gonorrhoeae.

Authors:  Manju Bala; Seema Sood
Journal:  J Glob Infect Dis       Date:  2010-09

Review 5.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

6.  Neisseria gonorrhoeae non-susceptible to cephalosporins and quinolones in Northwest Ethiopia.

Authors:  Martha Tibebu; Ambachew Shibabaw; Girmay Medhin; Afework Kassu
Journal:  BMC Infect Dis       Date:  2013-09-05       Impact factor: 3.090

7.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.